USA jobs

Radiopharmaceuticals Market 2023-2028: Industry Size, Share, Growth Opportunities

No comments

The latest report published by IMARC Group, titled “Radiopharmaceuticals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on radiopharmaceuticals market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global radiopharmaceuticals market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.

Radiopharmaceuticals represent a specialized category of pharmaceuticals that are infused with radioisotopes. These distinct formulations have several uses in the detection and treatment of different illnesses, notably in the area of nuclear medicine. They provide critical insights through imaging techniques, allowing healthcare professionals to visualize the function and structure of the body’s organs. These compounds play a vital role in detecting and staging diseases, such as cancer, and aid in the therapeutic treatment of certain conditions. With a focus on precision, radiopharmaceuticals enable targeted treatment, minimizing damage to surrounding healthy tissues. As a groundbreaking technological innovation, radiopharmaceuticals are gaining significance in contemporary medical practices, establishing themselves as essential tools in both diagnostic and therapeutic applications.

Request to Get the Sample Report: https://www.imarcgroup.com/radiopharmaceuticals-market/requestsample

Market Trends:

Other Post You May Be Interested In

The global radiopharmaceutical market is witnessing robust growth, driven by several contributing factors. Foremost among these is the rising prevalence of chronic diseases such as cancer, where radiopharmaceuticals are instrumental in early detection and targeted therapy. The emergence of advanced technologies in nuclear medicine, coupled with increased investment in research and development, is further propelling the market. Additionally, the growing emphasis on personalized medicine, which relies on precision diagnostics, aligns well with the capabilities of radiopharmaceuticals, adding to market momentum. Concurrently, governments and regulatory bodies are showing support by approving new radiopharmaceutical products and ensuring their safety, thus instilling confidence among healthcare providers and patients. On the environmental front, efforts toward producing radiopharmaceuticals with minimal waste and lower radiation exposure resonate with global sustainability initiatives. Furthermore, partnerships between pharmaceutical companies and academic institutions foster innovation and widen the application scope. Collectively, these drivers are shaping the trajectory of the global radiopharmaceuticals market, signaling a promising future that aligns with evolving healthcare needs and standards.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/radiopharmaceuticals-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Advanced Accelerator Applications (Novartis AG)
  • Bayer AG
  • Bracco S.p.A.
  • Cardinal Health Inc.
  • Curium Pharma
  • General Electric Company
  • IBA RadioPharma Solutions
  • Jubilant Pharma Limited
  • Lantheus Medical Imaging Inc
  • Nordion Inc. (Sotera Health)
  • NTP Radioisotopes SOC Ltd
  • PharmaLogic Holdings Corp.
  • Siemens AG

Radiopharmaceuticals Market Segmentation:

Our report has categorized the market based on region, product type, application and end use.

Breakup by Product Type:

  • Diagnostic Nuclear Medicine
  • Therapeutic Nuclear Medicine

Breakup by Application:

  • Oncology
  • Cardiology
  • Neurology
  • Endocrinology
  • Others

Breakup by End Use:

  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Centers

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

SHARE NOW

Leave a Reply

Your email address will not be published. Required fields are marked *